"Bill's track record of success and expert knowledge in electron microscopy is an important addition to the team, as we make ready to bring our technology to market", said William R. Glover, III, CEO and Vice President of Research & Development. "With the strategic addition of Bill, I look forward to focusing on these final developmental stages of the Technology Roadmap", said Glover.
"We are very pleased to have Bill joining the team, he has been a long-time advisor providing valued guidance and initiative", said Thomas D. Abert, CFO and Vice President of Finance & Administration. "Bill brings a wealth of expertise and experience both in advanced technology and in the successful development of early stage companies", said Abert.
Bill Ward was the founder, president, and chief executive officer of ALIS Corporation, a premier developer and supplier of a new generation of focused-ion-beam (FIB) microscopes for the semiconductor, materials science and life sciences industries until the acquisition of ALIS by Carl Zeiss Corporation in 2006. Formerly, Bill was a founder of Micrion Corporation (NASDAQ: MICN), a global leader in FIB systems, where he served as senior vice president and chief technical officer for eighteen years. Prior to his experience at Micrion, he founded Ion Beam Technologies, the first ion microscope company in the U.S. Earlier, Bill was on the founding team and R&D manager at Varian's E-beam Lithography division. Earlier contributions in his field also include the automation design efforts of the early Ion Implanters.
A serial entrepreneur with many successes to his credit, Bill is considered one of the premier scientists and business leaders in the charged particle microscopy community. He has authored numerous scientific articles for a number of professional journals and has lectured throughout the world. Numerous patents have been granted to Bill for his breakthroughs in microscopy and semiconductor-related technology--still considered some of the most important innovations in his field. Recently, his inventive skills and patents were focused on the stabilization of the Gas Field Ion Source making possible a new generation of scanning charged particle microscopes, the Helium Ion Microscope.
About ZS Genetics
ZS Genetics is a privately held Massachusetts start-up that has developed the components and Intellectual Property for the next generation of DNA sequencing. This patented approach combines the power of electron beam microscopy with a proprietary nucleic acid labeling processes to read DNA sequences directly from digital images. ZS Genetics' long-read, single-molecule technology offers the prospect of significant advancements in genetic analysis, with applications in the DNA sequencing and diagnostics markets.
ZS Genetics, Inc.
Thomas D. Abert
603.847.9143
tda@zsgenetics.com
www.zsgenetics.com